Diffusion Tensor Imaging Shows Different Topographic Involvement of the Thalamus in Progressive Supranuclear Palsy and Corticobasal Degeneration

References

1. 1.↵
   1. Di Maria E,
   2. Tabaton M,
   3. Vigo T,
   4. et al

   . Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 2000; 47: 374– 77

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Hattori M,
   2. Hashizume Y,
   3. Yoshida M,
   4. et al

   . Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol 2003; 106: 143– 49 Epub 2003 May 2

   CrossRefPubMed
3. 3.↵
   1. Arvanitakis Z,
   2. Wszolek ZK

   . Recent advances in the understanding of tau protein and movement disorders. Curr Opin Neurol 2001; 14: 491– 97

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Litvan I,
   2. Agid Y,
   3. Calne D,
   4. et al

   . Clinical research criteria for the diagnosis of progressive supranuclear palsy Steele-Richardson-Olszewski syndrome: report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1– 9

   Abstract/FREE Full Text
5. 5.↵
   1. Jankovic J,
   2. Tolosa E

   1. Kumar R,
   2. Bergeron C,
   3. Pollanen MS,
   4. et al

   . Jankovic J, Tolosa Eeds. Cortical-basal ganglionic degeneration. Parkinson's Disease and Movement Disorders. 3rd ed. Baltimore: Williams & Wilkins Press; 1998: 297– 316
6. 6.↵
   1. Maher ER,
   2. Lees AJ

   . The clinical features and natural history of the Steele-Richardson-Olszewski syndrome progressive supranuclear palsy. Neurology 1986; 36: 1005– 08

   Abstract/FREE Full Text
7. 7.↵
   1. Soliveri P,
   2. Monza D,
   3. Paridi D,
   4. et al

   . Cognitive and magnetic resonance aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999; 53: 502– 07

   Abstract/FREE Full Text
8. 8.↵
   1. Soliveri P,
   2. Monza D,
   3. Paridi D,
   4. et al

   . Neuropsychology follow-up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000; 69: 313– 18

   Abstract/FREE Full Text
9. 9.↵
   1. Litvan I,
   2. Phipps M,
   3. Pharr VL,
   4. et al

   . Randomized placebo controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology 2001; 57: 467– 73

   Abstract/FREE Full Text
10. 10.↵
    1. Cummings JL

    . Frontal-subcortical circuits in human behavior. Arch Neurol 1993; 50: 873– 80

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Schneider JA,
    2. Watts RL,
    3. Gearing M,
    4. et al

    . Corticobasal degeneration: neuropathological and clinical heterogeneity. Neurology 1997; 48: 959– 69

    Abstract/FREE Full Text
12. 12.↵
    1. Savoiardo M,
    2. Strada L,
    3. Girotti F,
    4. et al

    . MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 1989; 13: 555– 60

    PubMedWeb of Science
13. 13.↵
    1. Savoiardo M,
    2. Girotti F,
    3. Strada L,
    4. et al

    . Magnetic resonance imaging in progressive supranuclear palsy and in other parkinsonian disorders. J Neural Transm Suppl 1994; 42: 93– 110

    PubMed
14. 14.↵
    1. Cordato NJ,
    2. Duggins AJ,
    3. Halliday GM,
    4. et al

    . Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005; 128: 1259– 66

    Abstract/FREE Full Text
15. 15.↵
    1. Boxer AL,
    2. Geschwind MD,
    3. Belfor N,
    4. et al

    . Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006; 63: 81– 86

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Basser PJ,
    2. Mattiello J,
    3. LeBihan D

    . Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994; 103: 247– 54

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Jiang H,
    2. van Zijl PC,
    3. Kim J,
    4. et al

    . DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006; 81: 106– 16

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Wiegell MR,
    2. Tuch DS,
    3. Larsson HB,
    4. et al

    . Automatic segmentation of thalamic nuclei from diffusion tensor magnetic resonance imaging. Neuroimage 2003; 19: 391– 401

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Niemann K,
    2. Mennicken VR,
    3. Jeanmonod D,
    4. et al

    . The Morel stereotactic atlas of the human thalamus: atlas-to-MR registration of internally consistent canonical model. NeuroImage 2000; 12: 601– 16

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Picard N,
    2. Strick PL

    . Motor areas of the medial wall: a review of their location and functional activation. Cereb Cortex 1996; 6: 342– 53

    Abstract/FREE Full Text
21. 21.↵
    1. Padovani A,
    2. Borroni B,
    3. Brambati SM,
    4. et al

    . Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2006; 77: 457– 63

    Abstract/FREE Full Text
22. 22.↵
    1. Paviour DC,
    2. Price SL,
    3. Stevens JM,
    4. et al

    . Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005; 64: 675– 79

    Abstract/FREE Full Text
23. 23.↵
    1. Steele JC,
    2. Richardson JC,
    3. Olszewski J

    . Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333– 59

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Lantos PL

    . The neuropathology of progressive supranuclear palsy. J Neural Transm Suppl 1994; 42: 137– 52

    PubMed
25. 25.↵
    1. Matsumoto R,
    2. Nakano I,
    3. Arai N,
    4. et al

    . Progressive supranuclear palsy with asymmetric lesions in the thalamus and cerebellum, with special reference to the unilateral predominance of many torpedoes. Acta Neuropathol 1996; 92: 640– 44

    CrossRefPubMed
26. 26.↵
    1. Henderson JM,
    2. Carpenter K,
    3. Cartwright H,
    4. et al

    . Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000; 123: 1410– 21

    Abstract/FREE Full Text
27. 27.↵
    1. Seppi K,
    2. Schocke MF,
    3. Esterhammer R,
    4. et al

    . Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003; 60: 922– 27

    Abstract/FREE Full Text
28. 28.↵
    1. Hardman CD,
    2. Halliday GM

    . The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy. Mov Disord 1999; 14: 626– 33

    CrossRefPubMedWeb of Science
29. 29.↵
    1. DeVito JL,
    2. Anderson ME

    . An autoradiographics study of efferent connections of the globus pallidus in Macaca mulatta. Exp Brain Res 1982; 46: 107– 17

    PubMedWeb of Science
30. 30.↵
    1. Strick PL

    . Anatomical analysis of ventrolateral thalamic input to primate motor cortex. J Neurophysiol 1976; 39: 1020– 31

    Abstract/FREE Full Text
31. 31.↵
    1. Schell GR,
    2. Strick PL

    . The origin of thalamic inputs to the arcuate premotor and supplementary motor area. J Neurosci 1984; 4: 539– 60

    Abstract
32. 32.↵
    1. Halliday GM,
    2. Macdonald V,
    3. Henderson JM

    . A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Brain 2005; 128( pt 10): 2272– 80

    Abstract/FREE Full Text
33. 33.↵
    1. Nicoletti G,
    2. Lodi R,
    3. Condino F,
    4. et al

    . Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006; 129( pt 10): 2679– 87 Epub 2006 Jun 30

    Abstract/FREE Full Text
34. 34.↵
    1. Soliveri P,
    2. Piacentini S,
    3. Girotti F

    . Limb apraxia and cognitive impairment in progressive supranuclear palsy. Neurocase 2005; 11: 263– 67

    CrossRefPubMed
35. 35.↵
    1. Tsuboi Y,
    2. Slowinski J,
    3. Joseph KA,
    4. et al

    . Atrophy of the superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003; 60: 1766– 69

    Abstract/FREE Full Text
36. 36.↵
    1. Dickson DW,
    2. Bergeron C,
    3. Chin SS,
    4. et al

    . Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935– 46

    PubMedWeb of Science
37. 37.↵
    1. Rebeiz JJ,
    2. Kolodny EH,
    3. Richardson EP

    . Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18: 20– 33

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Gibb WR,
    2. Luthert PJ,
    3. Marsden CD

    . Corticobasal degeneration. Brain 1989; 112: 1171– 92

    Abstract/FREE Full Text
39. 39.↵
    1. Savoiardo M,
    2. Grisoli M,
    3. Girotti F

    . Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementia. Adv Neurol 2000; 82: 197– 208

    PubMedWeb of Science
40. 40.↵
    1. Josephs KA,
    2. Whitwell JL,
    3. Dickson DW,
    4. et al

    . Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008; 29: 280– 89

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Brooks DJ

    . Functional imaging studies in corticobasal degeneration. Adv Neurol 2000; 82: 209– 15

    PubMedWeb of Science
42. 42.↵
    1. Borroni B,
    2. Garibotto V,
    3. Agosti C,
    4. et al

    . White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol 2008; 65: 796– 801

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Rizzo G,
    2. Martinelli P,
    3. Manners D,
    4. et al

    . Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 2008; 131: 2690– 700

    Abstract/FREE Full Text
44. 44.↵
    1. Wedeen VJ,
    2. Wang RP,
    3. Schmahmann JD,
    4. et al

    . Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers. Neuroimage 2008; 41: 1267– 77

    CrossRefPubMedWeb of Science